×
About 58,653 results

ACR Updates Guidelines for Glucocorticoid-Induced Osteoporosis
https://www.clinicaladvisor.com/home/topics/rheumatology-information-center/acr-updates-guidelines-for-prevention-and-treatment-of-glucocorticoid-induced-osteoporosis/
Clinical Advisor

Oct 3rd, 2022 - The American College of Rheumatology (ACR) updated their 2017 ACR guidelines for preventing and treating glucocorticoid-induced osteoporosis (GIOP). The full manuscript will be published in Arthritis & Rheumatology and Arthritis Care and Research in early 2023. Since the publication of the 2017 ACR guidelines for GIOP, treatments, including abaloparatide (PTHrP) and romosozumab, have been avail...

Atopic Dermatitis Not Linked to VTE or JAK Inhibitors
https://www.dermatologyadvisor.com/home/topics/dermatitis/janus-kinase-inhibitors-jak-inhibitors-not-associated-with-vte-in-atopic-dermatitis/
Dermatology Advisor

Oct 3rd, 2022 - Atopic dermatitis (AD) is not associated with an increased risk for venous thromboembolism events, and neither are JAK inhibitors when used to treat AD, according to data from a systematic review and meta-analysis published in JAMA Dermatology. Investigators conducted a comprehensive literature search on electronic databases for cohort studies analyzing the association of AD with incident venou...

Postop analgesia in Saudi Arabia and the United States: A resident’s perspective
https://www.mdedge.com/psychiatry/article/258314/addiction-medicine/postop-analgesia-saudi-arabia-and-united-states
Hashem N. Akbar, MD

Oct 3rd, 2022 - I had the opportunity to experience first-hand acute postoperative pain management in both the United States and Saudi Arabia. In this article, I discuss some of the differences in how postop pain is managed in each location, potential reasons for these differences, how they may impact patients over time, and the psychiatrist’s role in raising awareness about the hazards of overprescribing anal.

Top pregnancy apps for your patients
https://www.mdedge.com/obgyn/article/258358/obstetrics
Gabriela Frid, BS, Katherine T. Chen, MD, MPH

Oct 2nd, 2022 - Pregnancy apps are more popular as patients use the internet to seek information about pregnancy and childbirth. 1 Research has shown that over 50% of pregnant patients download apps focused on pregnancy, with an average of 3 being tried.

Models stratify hysterectomy risk with benign conditions
https://www.mdedge.com/obgyn/article/258383/hysterectomy/models-stratify-hysterectomy-risk-benign-conditions
Marcia Frellick

Oct 2nd, 2022 - New models can help predict whether women having a hysterectomy for benign conditions are likely to have major complications, according to researchers. The models, which use routinely collected data, are meant to aid surgeons in counseling women before surgery and help guide shared decision-making.

AGA Clinical Practice Update: Expert review of management of refractory celiac disease
https://www.mdedge.com/internalmedicine/article/258320/gastroenterology/aga-clinical-practice-update-expert-review
Carolyn Crist

Sep 30th, 2022 - The diagnosis and management of refractory celiac disease remains challenging, but ongoing studies can provide the proper diagnostic criteria and identify the optimal management strategies, according to a new American Gastroenterological Association expert review published in Gastroenterology. Celiac disease is present in about 1% of the U.

Hormones' Impact Described in Transgender Rheumatology Patients
https://www.medscape.com/viewarticle/981718

Sep 30th, 2022 - Gender-affirming hormone therapy's effect on transgender patients with rheumatic disease is unclear but does not appear to modulate its course and does not need to be strictly contraindicated in most patients, according to a case series and systematic literature review. Dr Kristen Mathias More doctors are practicing transgender medicine, yet a limited amount of information is available on rheum...

ACR Updates Guidelines for Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
https://www.endocrinologyadvisor.com/home/topics/bone-metabolism/acr-updates-guidelines-for-prevention-and-treatment-of-glucocorticoid-induced-osteoporosis/
Endocrinology Advisor

Sep 29th, 2022 - The American College of Rheumatology (ACR) updated their 2017 ACR guidelines for preventing and treating glucocorticoid-induced osteoporosis (GIOP). The full manuscript will be published in Arthritis & Rheumatology and Arthritis Care and Research in early 2023. Since the publication of the 2017 ACR guidelines for GIOP, treatments, including abaloparatide (PTHrP) and romosozumab, have been avail...

Misinformation Common in Acne Vulgaris
https://www.dermatologyadvisor.com/home/topics/acne/misinformation-common-in-acne-vulgaris/
Dermatology Advisor

Sep 29th, 2022 - Dermatologists should be aware of misinformation regarding acne vulgaris and counter it with evidence-based practice with their patients, according to findings from a study published in Clinical and Experimental Dermatology. Researchers assessed online misinformation regarding acne by conducting a literature search on PubMed, which ultimately yielded 5 papers for their review. They also perform...

Commentary: Organ Preservation and KRASG12C in CRC, October 2022
https://www.mdedge.com/hematology-oncology/article/258288/gastrointestinal-cancer/commentary-organ-preservation-and
Thomas Abrams, MD

Sep 29th, 2022 - Dr. Thomas Abrams, MD As always, several provocative publications on colorectal cancer (CRC) have found their way into the medical literature.

Researchers share guidelines for inclusive language in autism research
https://www.eurekalert.org/news-releases/965562

Sep 29th, 2022 - In the decades since the “clinical” definitions of autism in the 1980s, many have been advocating to understand autism as a normal part of the neurodiversity spectrum rather than as a “problem” to be “fixed.” Still, in the research literature, autism is often described using medical or pathologizing language. To make autism research less harmful to the autistic community, researchers publishing...

Ovarian Cancer Clinical Practice Guidelines (NCCN, 2022)
https://www.medscape.com/viewarticle/979889

Sep 29th, 2022 - Updated guidelines on the diagnosis and treatment of ovarian cancer were published on September 10, 2022 by the National Comprehensive Cancer Network in the Journal of the National Comprehensive Cancer Network.[1] Treatment options for elderly patients (age >70 years) and/or those with comorbidities are as follows: Intravenous (IV) paclitaxel, 135 mg/m2 plus IV carboplatin, area under the curve...

Olokizumab Shows Efficacy After Nonresponse to TNF Inhibitors
https://www.medscape.com/viewarticle/981624

Sep 29th, 2022 - Treatment of rheumatoid arthritis with olokizumab combined with methotrexate led to significantly more patients with improved signs and symptoms than did methotrexate plus placebo in circumstances where previous treatment with one or more tumor necrosis factor (TNF) inhibitors yielded inadequate responses, results from a phase 3 randomized trial show. At the week 12 primary endpoint, 40.6% of p...

Trial shows olokizumab’s effect in nonresponders to TNF inhibitors in RA
https://www.mdedge.com/rheumatology/article/258281/rheumatoid-arthritis/trial-shows-olokizumabs-effect-nonresponders-tnf
Ashley Lyles

Sep 28th, 2022 - Treatment of rheumatoid arthritis with olokizumab combined with methotrexate led to significantly more patients with improved signs and symptoms than did methotrexate plus placebo in circumstances where previous treatment with one or more tumor necrosis factor (TNF) inhibitors yielded inadequate responses, results from a phase 3 randomized trial show. At the week 12 primary endpoint, 40.

The Bionic Pancreas Triumphs in Pivotal Trial
https://www.medscape.com/viewarticle/981396

Sep 28th, 2022 - Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine. It was 100 years ago when Leonard Thompson, age 13, received a reprieve from a death sentence. Young master Thompson had type 1 diabetes, a disease that was uniformly fatal within months of diagnosis. But he received a new treatment, insulin, from a canine panc...

USPSTF: Screen At-Risk, Nonpregnant People for Syphilis
https://www.medscape.com/viewarticle/981605

Sep 28th, 2022 - People increased risk for syphilis — including asymptomatic, nonpregnant adolescents and adults who have ever been sexually active and are at high risk for the disease — should be screened for it, according to a reaffirmation by the United States Preventive Services Task Force (USPSTF) of its 2016 recommendation of syphilis screening for people at increased risk for infection. "Using a reaffirm...

New Guidance on Acupuncture, Massage, Yoga for Cancer Pain
https://www.medscape.com/viewarticle/981558

Sep 28th, 2022 - New guidelines highlight the role that integrative pain management techniques, such as massage, acupuncture, and music therapy, can play in relieving certain types of cancer pain in adults. The recommendations, published earlier this month in the Journal of Clinical Oncology, represent a joint effort between the American Society of Clinical Oncology (ASCO) and the Society of Integrative Oncolog...

MRI findings in opioid-exposed fetuses show smaller brain size
https://www.eurekalert.org/news-releases/965876

Sep 28th, 2022 - Leesburg, VA, September 28, 2022—According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR), third-trimester fetuses with in utero opioid exposure exhibited multiple smaller 2D biometric measurements of the brain, as well as altered fetal physiology, on investigational MRI. Noting the scarcity of imaging literature evaluating prenatal opioid exposure on...

COVID-19 drives new research into smell loss
https://www.eurekalert.org/news-releases/966117

Sep 28th, 2022 - COVID-19 has left thousands with a distorted or lost sense of smell, but some of those who have been affected are helping researchers get a better handle on the phenomenon. This understanding and growing awareness of olfactory disorders could help people facing smell loss from COVID-19 or other causes, according to a cover story in Chemical & Engineering News, an independent news outlet of the ...

Human Papillomavirus Vaccine in Patients With Palmoplantar Warts
https://www.dermatologyadvisor.com/home/topics/general-dermatology/hpv-vaccine-in-patients-with-palmoplantar-warts/
Dermatology Advisor

Sep 27th, 2022 - The quadrivalent or nonavalent human papillomavirus (HPV) vaccine in patients with palmoplantar warts may be efficient. The vaccine is well tolerated although there is a high failure rate in the management of palmoplantar warts after salicylic acid or liquid nitrogen have been used. These are among the study findings published in the Journal of the European Academy of Dermatology and Venereolog...